Streamex Corp. (STEX) is a Healthcare stock trading at $0.82 (as of 2026-08-20), with a market capitalization of $85.66M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
Streamex Corp. provides institutional-grade infrastructure to tokenize real-world assets, with a focus on gold- and commodities-backed tokenization using blockchain technology, powered by a gold-denominated treasury.
Profitability is driven by scaling tokenized asset activity tied to its gold- and commodities-backed infrastructure, especially gold-denominated assets under management and related distributions accessed through its tokenization platform.
Business quality (Weak): The business has a clear thematic profit engine around tokenizing gold- and commodities-backed real-world assets, but the latest reported quarter shows very large operating losses, and the company has recently rebranded and changed its focus following a merger.
| Price | $0.82 |
| Market Cap | $85.66M |
| Price / Book | 0.58 |
| Price / Sales | 432.64 |
| Revenue (TTM) | $40000.00 |
| Net Margin | -25825.0% |
| Revenue Growth (YoY) | 122.2% |
| EPS Growth (YoY) | -81.0% |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| Top Institutional Holder | Legacy Wealth Managment, LLC/ID ($7.94M) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Karl Henry McPhie |
| Employees | 5 |
| Country | US |
| IPO Date | 2025-09-12 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.